Ruth L Goodall

University College London

United Kingdom

Research Interests

Explore related searches

Professors in United Kingdom

Contact this professor

Get a free first email built on one of their papers, ready for you to edit and send yourself.

Articles (10)

Year:

2024

Year:

2022

Year:

2022

Year:

2022

Year:

2022

Year:

2022

Year:

2022

Year:

2022

Year:

2022

Year:

2022

Collaborators (6)

Tra My Pham

UNITED KINGDOM

View details

Eve Worrall

Reader in Health Economics

Liverpool School of Tropical Medicine

UNITED KINGDOM

View details

Santiago Pérez-Hoyos

Associate Professor

University of Barcelona

SPAIN

View details

Bhekumusa Wellington Lukhele

Assistant Professor, Global Health

University of Alabama, Tuscaloosa

UNITED STATES

View details

Patrick Phillips

Assistant Professor

University of California, San Francisco

UNITED STATES

View details

Lars Naver

Karolinska Institutet

SWEDEN

View details

ApplyKite TwinLearns as you apply

Make your next move.

Prepare your application

Review drafts before you send them.

Ruth L Goodall

Research Interests

Explore related searches

Contact this professor

Articles (10)

Comparative Efficacy and Safety of Moxifloxacin and Levofloxacin in a Short Standardised Rifampicin Resistant TB Regimen: A STREAM 2 Secondary Analysis

Growth and CD4 patterns of adolescents living with perinatally acquired HIV worldwide, a CIPHER cohort collaboration analysis

Rethinking intercurrent events in defining estimands for tuberculosis trials

Children living with HIV in Europe: do migrants have worse treatment outcomes?

Economic evaluation of shortened, bedaquiline-containing treatment regimens for rifampicin-resistant tuberculosis (STREAM stage 2): a within-trial analysis of a randomised controlled trial.

Keeping up with the guidelines: design changes to the STREAM stage 2 randomised controlled non-inferiority trial for rifampicin-resistant tuberculosis

ECG monitoring in STREAM Stage 1: can we identify those at increased risk of QT prolongation?

Evaluation of two short standardised regimens for the treatment of rifampicin-resistant tuberculosis (STREAM stage 2): an open-label, multicentre, randomised, non-inferiority trial.

Failure or relapse predictors for the STREAM Stage 1 short regimen for RR-TB.

QT prolongation in the STREAM Stage 1 Trial.

Collaborators (6)

Tra My Pham

Eve Worrall

Santiago Pérez-Hoyos

Bhekumusa Wellington Lukhele

Patrick Phillips

Lars Naver

Make your next move.